Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS +20.00%·Rev n/aQ3 25EPS +63.41%·Rev n/aQ2 25EPS -4.65%·Rev n/aQ1 25EPS -0.38%·Rev n/a⚠ consensus missing

Phathom Pharmaceuticals, Inc. PHAT

Eric Sciorilli — Head of Investor Relations

Steven Basta — President and CEO

Sanjeev Narula — Chief Financial and Business Officer

+10.4%1d on move date+10.8% vs SPY3d−8.3%5d−4.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PHAT calls or request research access.

More PHAT calls Browse calls Request research access